PMCB

3.97512.83%
JL

Jonathan L. Schechter

Independent Chairman of the Board

Mr. Jonathan L. Schechter, JD, serves as Independent Director at PharmaCyte Biotech, Inc. since August 15, 2022 and served as Director of Investment Banking at Chardan Capital Markets, LLC. He serves as Independent Director at TaoWeave, Inc. (formerly known as Oblong, Inc.) since May 2023 and serves as its Chairman of the Board since December 18, 2024. Mr. Schechter joined Chardan Capital Markets, LLC in 1998. Beginning in 1999, he worked as a Corporate Associate for Brian Cave LLP, where he specialized in representing investors and investment banks in capital market transactions. He also represented and advised numerous public companies in all aspects of corporate law. From 2005 to 2007, he served as General Counsel to a hedge fund. He contributes expertise in areas of corporate governance, mergers and acquisitions and investment banking to the Board. Mr. Schechter has served as the Director of Investment Banking at Chardan Capital Markets since February 2008. He serves as founding partner of The Special Equities Group since August 2019. He has been a Director of WPCS International Incorporated since March 30, 2017. He served as a Director of Atrinsic, Inc. since February 1, 2014. Mr. Schechter is one of the founding partners of The Special Equities Opportunity Fund since August 2019. He was a Director of TAO Synergies Inc. (formerly known as Synaptogenix, Inc.) until August 28, 2025. He previously served as a director of DropCar, Inc. and Neurotrope, Inc. He previously worked at Bradley Woods & Co., Ltd. Mr. Schechter graduated from Duke University, cum laude, with an AB in Public Policy and Political Science and with J.D. from Fordham University School of Law and is licensed to practice in the State of New York.

Positions